{
  "id": 2071120,
  "title": "Heartflow CMO Campbell Rogers sells $380k in shares",
  "url": "https://urgent.news/2026/08/20/heartflow-cmo-campbell-rogers-sells-380k-in-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-20T04:31:13.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/heartflow-cmo-campbell-rogers-sells-380k-in-shares-93CH-4868667"
  },
  "original_language": "en",
  "account": "Campbell Rogers, Chief Medical Officer at Heartflow Inc., sold approximately 9,219 shares of the company's stock on August 17, 2026, for a total of $380,099. This followed the exercise of stock options, which were part of a grant that vested in monthly installments until August 7, 2029. The shares were sold at a price of $41.23 each, and the stock has since increased to $45.53, nearing its 52-week high of $47.23. Despite the recent sale, the company's shares have surged 46.8% over the past week. Heartflow reported strong financial results for Q2 2026, posting a narrower-than-expected loss and a 48% increase in revenue to $64.1 million. Analysts do not anticipate profitability this year, and the stock is currently considered overvalued. Rogers indirectly owns shares through several trusts, and he also holds 82,972 stock options with an exercise price of $19.00.",
  "summary": null,
  "key_points": [
    "Campbell Rogers sold 9,219 Heartflow shares for $380,099 on August 17, 2026",
    "Shares increased 46.8% in one week despite Rogers' sale",
    "Rogers indirectly owns shares through trusts and holds 82,972 stock options"
  ],
  "editors_take": "The sale of nearly $380,000 in shares by Heartflow's CMO suggests a possible profit-taking move amid the company's surging stock price and strong recent financial results that have lifted its valuation.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}